Analyst Price Target is $22.00
▲ +425.06% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Bellerophon Therapeutics in the last 3 months. The average price target is $22.00, with a high forecast of $22.00 and a low forecast of $22.00. The average price target represents a 425.06% upside from the last price of $4.19.
Current Consensus is
The current consensus among 2 polled investment analysts is to buy stock in Bellerophon Therapeutics. This Buy consensus rating has held steady for over two years.